C.R.S. Section 25.5-5-311
Treatment program for high-risk pregnant and parenting women

25.5–5–101
Mandatory provisions - eligible groups - rules - repeal 25.5–5–102
Basic services for the categorically needy - mandated services 25.5–5–103
Mandated programs with special state provisions - rules 25.5–5–104
Qualified medicare beneficiaries 25.5–5–105
Qualified disabled and working individuals 25.5–5–201
Optional provisions - optional groups - rules - repeal 25.5–5–202
Basic services for the categorically needy - optional services 25.5–5–203
Optional programs with special state provisions - repeal 25.5–5–204
Presumptive eligibility - pregnant person - children - long-term care - state plan 25.5–5–204.5
Continuous eligibility - children 25.5–5–206
Medicaid buy-in program - disabled children - disabled adults - federal authorization - rules 25.5–5–207
Adult dental benefit - adult dental fund - creation - legislative declaration 25.5–5–208
Additional services - training - grants - screening, brief intervention, and referral 25.5–5–301
Clinic services 25.5–5–302
Clinic services - children and pregnant women - utilization of certain providers 25.5–5–303
Private-duty nursing 25.5–5–304
Hospice care 25.5–5–305
Pediatric hospice care - legislative declaration - federal authorization - rules - fund 25.5–5–307
Child mental health treatment and family support program 25.5–5–308
Breast and cervical cancer prevention and treatment program - creation - legislative declaration - definitions - funds - repeal 25.5–5–309
Pregnant women - needs assessment - referral to treatment program - definition 25.5–5–310
Treatment program for high-risk pregnant and parenting women - cooperation with private entities - definition 25.5–5–311
Treatment program for high-risk pregnant and parenting women - data collection 25.5–5–312
Treatment program for high-risk pregnant and parenting women - extended coverage - federal approval 25.5–5–314
Substance use disorder treatment for Native Americans - federal approval 25.5–5–315
Acceptance of gifts, grants, and donations - Native American substance abuse treatment cash fund 25.5–5–316
Legislative declaration - state department - disease management programs authorization - report 25.5–5–318
Health services - provision by school districts - repeal 25.5–5–319
Family planning pilot program - rules - federal waiver - repeal 25.5–5–320
Telemedicine - reimbursement - disclosure statement - rules - definition 25.5–5–321
Telemedicine - home health care - home health telemedicine cash fund - rules - repeal 25.5–5–321.5
Telehealth - interim therapeutic restorations - reimbursement - definitions 25.5–5–322
Over-the-counter medications - rules 25.5–5–323
Complex rehabilitation technology - no prior authorization - metrics - report - rules - legislative declaration - definitions 25.5–5–324
Nonemergency medical transportation - urgent and secure transportation need - report - repeal 25.5–5–325
Residential and inpatient substance use disorder treatment - medical detoxification services - federal approval - performance review report 25.5–5–326
Access to clinical trials - definitions 25.5–5–327
Eligible peer support services - reimbursement - definitions 25.5–5–328
Secure transportation for behavioral health crises - benefit - funding 25.5–5–329
Family planning services - federal authorization - rules - definitions 25.5–5–330
Screening for perinatal mood and anxiety disorder 25.5–5–331
Federally qualified health center - clinical pharmacy services - reimbursement - rules 25.5–5–332
Therapy using equine movement - federal authorization - definition 25.5–5–333
Primary care and behavioral health statewide integration grant program - creation - report - definition - repeal 25.5–5–334
Community health worker services - federal authorization - reporting - rules - definition 25.5–5–335
Continuous medical coverage for children and adults feasibility study - federal authorization - rules - report - definition 25.5–5–336
Prohibition on using the body mass index or ideal body weight - medical necessity criteria 25.5–5–401
Short title 25.5–5–402
Statewide managed care system - rules - definitions - repeal 25.5–5–403
Definitions 25.5–5–406.1
Required features of statewide managed care system 25.5–5–408
Capitation payments - availability of base data - adjustments - rate calculation - capitation payment proposal - preference - assignment of medicaid recipients - definition 25.5–5–410
Data collection for managed care programs 25.5–5–412
Program of all-inclusive care for the elderly - services - eligibility - legislative declaration - rules - definitions 25.5–5–414
Telemedicine - legislative intent 25.5–5–415
Medicaid payment reform and innovation pilot program - legislative declaration - creation - selection of payment projects - report - rules 25.5–5–418
Primary care provider sustainability fund - creation - use of fund 25.5–5–419
Accountable care collaborative - reporting - rules 25.5–5–420
Advancing care for exceptional kids 25.5–5–421
Parity reporting - state department - public input 25.5–5–422
Medication-assisted treatment - limitations on MCEs - definition 25.5–5–423
Independent review organization - review denial of residential and inpatient substance use disorder treatment claims - contract 25.5–5–424
Residential and inpatient substance use disorder treatment - MCE standardized utilization management process - medical necessity - report 25.5–5–425
Audit of MCE denials for residential and inpatient substance use disorder treatment authorization - report 25.5–5–500.3
Authorization to bill third party 25.5–5–501
Providers - drug reimbursement 25.5–5–502
Unused medications - reuse - rules - definition 25.5–5–503
Prescription drug benefits - authorization - dual-eligible participation 25.5–5–504
Providers of pharmaceutical services 25.5–5–505
Prescribed drugs - mail order - rules 25.5–5–506
Prescribed drugs - utilization review 25.5–5–507
Prescription drug information and technical assistance program - rules 25.5–5–509
Substance use disorder - prescription drugs - opiate antagonist 25.5–5–510
Pharmacy reimbursement - substance use disorder - injections 25.5–5–511
Reimbursement for pharmacists’ services - legislative declaration 25.5–5–512
Pharmacy benefit - mental health and substance use disorders - legislative declaration 25.5–5–513
Pharmacy benefits - prescription drugs - rebates - analysis 25.5–5–514
Prescription drugs used for treatment or prevention of HIV - prohibition on utilization management - definition 25.5–5–515
Pharmacy reimbursement - vaccine administration to children - legislative declaration 25.5–5–516
Serious mental illness - prescribed drugs 25.5–5–801
Legislative declaration 25.5–5–802
Definitions 25.5–5–803
High-fidelity wraparound services for children and youth - federal approval - reporting 25.5–5–804
Integrated funding pilot